Medical/Scientific Advisors


FCF strives to be in the forefront of research on fibrolamellar hepatocellular carcinoma. Several leading physicians, scientists and researchers in this field have agreed to be advisors to FCF. Each represents an institution or laboratory which is currently involved in research or treatment of fibrolamellar liver cancer.

Ghassan Abou-Alfa, M.D.

Attending Physician
Department of Medicine and Gastrointestinal Oncology Service
Memorial Sloan-Kettering Cancer Center, New York


chotiMichael Choti, M.D., M.B.A.

Professor and Chairman
Department of Surgery
UT Southwestern Medical Center, Dallas, Texas


dematteoRonald P. DeMatteo, M.D., FACS

Vice Chair, Department of Surgery
Head, Division of General Surgical Oncology
Memorial Sloan-Kettering Cancer Center, New York


laougliaMichael P. LaQuaglia, M.D., FACS, FRCS

Chief, Pediatric Surgical Service
Memorial Sloan-Kettering Cancer Center, New York


levineRon Levine, M.D.

Greenwich, Connecticut



JRCphoto - Dr. CraigJohn Craig, M.D.
Pathologist, Director of FCF
Carmel, California



Lola Reid, PH.D.

Department of Cell and Molecular Physiology
University of North Carolina, Chapel Hill, NC


simonSanford M. Simon, PH.D.

Head, Laboratory of Cellular Biophysics
The Rockefeller University, New York


torbensonMichael Torbenson, M.D.

Senior Associate Consultant
Department of Anatomic Pathology
Mayo Clinic, Rochester, Minnesota


Alan P. Venook, M.D.

Professor, Department of Medicine (Hematology/Oncology)
University of California, San Francisco, California